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ABSTRACT
Background and objective Diagnostic models used
in the management of suspected angina provide no
explicit information about prognosis. We present a new
prognostic model of 10-year coronary mortality in
patients presenting for the ﬁrst time with suspected
angina to complement the Diamond-Forrester diagnostic
model of disease probability.
Methods and results A multicentre cohort of 8762
patients with suspected angina was followed up for a
median of 10 years during which 233 coronary deaths
were observed. Developmental (n=4412) and validation
(n=4350) prognostic models based on clinical data
available at ﬁrst presentation showed good performance
with close agreement and the ﬁnal model utilised all
8762 patients to maximise power. The prognostic model
showed strong associations with coronary mortality for
age, sex, chest pain typicality, smoking status, diabetes,
pulse rate, and ECG ﬁndings. Model discrimination was
good (C statistic 0.83), patients in the highest risk
quarter accounting for 173 coronary deaths (10-year risk
of death: 8.7%) compared with a total of 60 deaths in
the three lower risk quarters. When the model was
simpliﬁed to incorporate only Diamond-Forrester factors
(age, sex and character of symptoms) it underestimated
coronary mortality risk, particularly in patients with
reversible risk factors.
Conclusions For the ﬁrst time in patients with
suspected angina, a prognostic model is presented based
on simple clinical factors available at the initial
cardiological assessment. The model discriminated
powerfully between patients at high risk and lower risk
of coronary death during 10-year follow-up. Clinical
utility was reﬂected in the prognostic value it added to
the updated Diamond-Forrester diagnostic model of
disease probability.
INTRODUCTION
In the patient with stable chest pain, the diagnosis
of coronary artery disease (CAD) is a probability
judgement based on clinical presentation and
disease prevalence in the population group to
which the patient belongs. Quantitative analysis of
disease probability was provided by Diamond and
Forrester based on patient age, gender and typical-
ity of symptoms.1 The Diamond-Forrester estimate
of disease probability, its recent update2 and its
modiﬁcation in the Duke clinical score3 lie at the
heart of contemporary guidelines for the manage-
ment of patients with suspected angina.4–6
However, these diagnostic models provide no expli-
cit information about prognosis and many patients
diagnosed with atypical or non-cardiac chest pain
based on low estimates of disease probability
experience coronary events during follow-up.7 The
importance of prognostic assessment is emphasised
in stable coronary disease guidelines,5 8 but prog-
nostic models have not previously been developed
in patients with suspected angina among whom
outcomes are likely to vary considerably according
to the presence and severity of CAD. A prognostic
model to identify those high-risk patients who fall
through the diagnostic net would provide an
opportunity for treatment to protect against myo-
cardial infarction and coronary death.9
In the present study we have examined associa-
tions between clinical variables available at ﬁrst
consultation and 10-year coronary mortality in a
large cohort of patients presenting for cardiac
assessment of previously undiagnosed chest pain.
The main aim was to develop a new prognostic
model of the 10-year coronary mortality risk in
patients with suspected angina to complement the
Diamond-Forrester diagnostic model of disease
probability in their work-up and further
management.
METHODS
Patients
The patient population has been previously
described.7 In brief, we included consecutive
patients attending six UK chest pain clinics
(Newham, Oldchurch, Kingston, Blackburn,
Manchester, Burnley). The purpose of the clinics
was to identify patients with angina to initiate
appropriate treatment, including secondary preven-
tion with aspirin and statins. Data on 11 082
patients were electronically recorded from 2
January 1996 to 31 December 2002 using identical
databases, details of which have been reported pre-
viously.10 We excluded re-attendances during the
study period (n=448), patients without chest pain
(n=291), patients diagnosed with acute coronary
syndromes on the day of visit (n=246), patients
who reported previously diagnosed coronary heart
disease or revascularisation procedures (n=579),
patients for whom a diagnosis was either not
entered (n=132) or not identiﬁed as angina or non-
cardiac chest pain (n=83), those with missing data
on key explanatory variables (n=501), and those
who were not traced by the national death
registry (n=40).11 The remaining 8762 patients
with complete data and follow-up constituted the
study group.
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Data collection
Clinical data were systematically recorded at the time of the
initial consultation in a purpose-built electronic database that
was utilised across the six study centres. The data included age,
sex, ethnicity, clinical descriptors of chest pain (duration of
symptoms before attendance, character, site and radiation of
chest pain, duration of an episode, precipitating factors and
relief with glyceryl trinitrate), smoking status, history of hyper-
tension and diabetes, pulse rate, and systolic blood pressure.
Twelve-lead resting ECGs were recorded as normal or abnormal,
respectively, depending on assessment of rhythm, conduction,
and the absence or presence of regional ST segment or T wave
changes, left ventricular hypertrophy, and Q waves. Fields for
all these clinical and ECG ﬁndings were included in the database
and were populated by the attending clinicians during consult-
ation in the chest pain clinic. Clinicians were also invited to
enter into the electronic record their assessment of the patient’s
chest pain as being ‘typical’, ‘atypical’ or ‘non-anginal’.
Follow-up
Patients were ﬂagged for mortality with the Ofﬁce for National
Statistics (to 31 December 2011).11 Successful matching was
achieved in 99.5% of the cohort. Causes of death were deﬁned
by the WHO International Classiﬁcation of Diseases (ICD-10
codes). Information about non-fatal events was unavailable
because ﬂagging of our patients with the NHS-wide clearing
system had terminated in 2003.
Main outcome measures
The primary end point was death due to coronary heart disease
(ICD-10 I20–I25). The secondary end point was cardiovascular
death (ICD-10 I00–I99).
Bias
Bias in patient selection and data collection was minimised by
including consecutive patients attending for the ﬁrst time with
suspected angina and by utilising a standardised electronic data-
base across all study centres. Bias due to the variable demo-
graphic characteristics of the clinic populations was minimised
by including a mixture of urban and suburban centres in this
multicentre study.
Ethical approval
Ethical approval was obtained from the multiregional ethics
committee (MREC/02/04/095). Permission was given by the
National Patient Information Advisory Group to link anon-
ymised datasets without individual patient consent.12
Statistical analysis
To derive the new prognostic model to predict coronary death
we initially used data from the Newham centre (n=4412) as the
development dataset because it comprised approximately half of
all patients enrolled. Validation was assessed with data from the
other ﬁve centres (n=4350) by applying the coefﬁcients of the
model from the development dataset to the validation dataset.
Overall rates and rates by categories of the candidate predictors
were calculated. For all variables of interest, data were complete
or in two cases >99% complete (table 1). Cox proportional
hazard models (complete case analysis) were used to estimate the
univariable and multivariable associations of the predictor vari-
ables with coronary death. Candidate variables included demo-
graphics, cardiovascular disease risk factors, chest pain
characteristics, and ECG ﬁndings. We included these variables
because they have been reported as predictors in previous prog-
nostic models in related populations.13–15 Predictor variables
independently associated with coronary disease mortality were
identiﬁed using a manual forward stepwise approach rather than
an automated stepwise procedure to allow for clinical judgement
and for variables not at ﬁrst meeting the criterion for inclusion
in the ﬁnal multivariate model to be later reconsidered.
Smoking, for example, was forced into the ﬁnal model based on
its well-established association with coronary mortality. There
are several measures to assess characteristics of chest pain. It was
decided a priori that the symptoms of chest pain (typical, atyp-
ical or non-cardiac chest pain) should be the assessment included
as it is easily measured without the need for further diagnosis
and is the measure included in previous scores. The linear rela-
tionship of quantitative variables was considered and grouped
into appropriate categories where necessary or for ease of inter-
pretation. The risk of dying within 10 years from a coronary
cause was calculated for each individual using Kaplan-Meier esti-
mates to allow that a number of individuals had <10 years of
follow-up (but >9 years). Individuals were then divided into
fourths of risk based on the quartile cut-points so that there
were 25% of patients in each risk group. The Kaplan-Meier sur-
vival curves were then plotted for each of these groups.
Agreement was very good between the development and val-
idation datasets, indicating that any bias consequent on single
site (Newham) model development was minimal. In addition, a
separate model was produced in the validation dataset using the
variables identiﬁed in the development dataset. There was close
similarity in the associations of predictor variables with coron-
ary disease mortality in the two models, and therefore in order
to maximise power and the precision of the estimates, the prog-
nostic model was ﬁnalised using all 8762 individuals. The per-
formance of the model was assessed in terms of calibration and
discrimination. Calibration was assessed graphically by plotting
the observed outcomes compared with the predicted probabil-
ities (by quartiles of risk) and using the Hosmer-Lemeshow
goodness-of-ﬁt test. Discrimination was estimated by calculating
the area under the receiver operating curve (C-statistic).
Risk estimates of CAD were calculated according to the
updated Diamond-Forrester diagnostic model proposed by
Genders.2 The predicted risk of CAD was then tabulated by the
observed mortality to see how well previously published models
for CAD risk predicted actual 10-year mortality due to coronary
heart disease. Additional analyses also tabulated predicted CAD
risk by all-cause mortality and cardiovascular mortality.
Model presentation: online risk calculator
A prognosis in suspected angina (PISA) calculator utilising our
model coefﬁcients is available at https://www.sealedenvelope.
com/trials/pisa/ allowing the estimated 10-year risks of coronary
and cardiovascular mortality to be obtained for individual
patients at the time of consultation (ﬁgure 1). By entering the
predictor values the PISA mortality estimates are displayed and
also the updated Diamond-Forrester estimates of disease
probability.2
Role of funders
Study funders acknowledged below played no role in the data
collection, or its analysis and interpretation.
RESULTS
The 8762 patients were followed up for a median of 10 years
(minimum 9 years). Two hundred and thirty-three coronary
deaths were recorded, representing a rate of 2.9 deaths per
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1000 patient years. Patients in the highest quarter of risk were
older and more commonly male compared with patients in the
lower risk quarters (see online supplementary table S1). The fre-
quency of diabetes and typical angina symptoms increased
across quarters of risk.
Model development and validation
The model produced in the development dataset (see online
supplementary table S2) and its external validation in the valid-
ation dataset (see online supplementary table S3) both showed
good discrimination (c=0.84 and 0.82, respectively), and good
calibration (see online supplementary ﬁgure S1). Because exter-
nal validation was good and multivariate associations with cor-
onary death were similar in both the developmental and
validation datasets (see online supplementary tables S2 and S3),
the ﬁnal prognostic model was developed among all 8762
patients to maximise power. The ﬁnal model, based on clinical
factors available at the ﬁrst presentation, showed strong associa-
tions with coronary disease mortality for age, sex, chest pain
typicality, smoking status, diabetes, pulse rate, and ECG ﬁndings
(tables 1 and 2). Discrimination (c=0.83) and calibration (table
2 and online supplementary ﬁgure S2) were strong, with
patients in the highest quarter of risk accounting for 173 coron-
ary deaths during follow-up (10 year risk of death:8.7%) com-
pared with a total of 41, 14, and 5 deaths, respectively, in the
lower risk quarters. Kaplan-Meier analysis conﬁrmed wide and
increasing separation of the survival curves for the highest risk
quarter compared to the three lower risk quarters throughout
the 10-year follow-up period (ﬁgure 2). Entry of the seven pre-
dictor variables into the online prognosis in stable angina (PISA)
risk calculator at https://www.sealedenvelope.com/trials/pisa/
permits display of an individual patient’s risk estimates of cor-
onary and cardiovascular mortality and also the Diamond-
Forrester diagnostic estimates of disease probability (ﬁgure 1).
Table 1 Univariable associations with coronary death: all patients
Total Deaths Rate* HR (95% CI) p Value
All patients 8762 233 2.9
Age (per 10 years) 8762 233 2.46 (2.19 to 2.76) <0.0001
Age group
<50 3341 22 0.68 1
50 to <55 1151 17 1.54 2.27 (1.20 to 4.27) 0.011
55 to <60 1163 21 1.92 2.82 (1.55 to 5.12) 0.0007
60 to <65 1040 30 3.13 4.58 (2.64 to 7.94) <0.0001
65 to <70 881 29 3.66 5.33 (3.06 to 9.28) <0.0001
70 to <75 645 46 8.24 11.94 (7.19 to 19.85) <0.0001
75 to <80 356 35 12.63 18.05 (10.59 to 30.77) <0.0001
80+ 185 33 26.12 36.65 (21.35 to 62.91) <0.0001
Sex
Female 4168 80 2.04 1
Male 4594 153 3.61 1.76 (1.34 to 2.31) <0.0001
Ethnicity
Other 2977 46 1.61 1
White 5785 187 3.54 2.18 (1.58 to 3.00) <0.0001
Pulse rate (per 10 bpm) 8762 233 1.21 (1.10–1.33) 0.0001
SBP (10 mm Hg) 8762 233 1.20 (1.13–1.27) <0.0001
DBP (10 mm Hg) 8711 231 1.15 (1.03–1.29) 0.014
Current smoker
No 6667 174 2.80 1
Yes 2095 59 3.06 1.09 (0.81 to 1.47) 0.55
Hypertension
No 5717 118 2.20 1
Yes 3045 115 4.14 1.87 (1.45 to 2.42) <0.0001
Diabetes
No 7844 178 2.43 1
Yes 918 55 6.63 2.71 (2.00 to 3.67) <0.0001
Family history of CAD
No 5851 161 2.98 1
Yes 2880 70 2.58 0.87 (0.66 to 1.15) 0.33
Character symptoms
Atypical 5079 93 1.95 1
Typical 2002 115 6.44 3.28 (2.50 to 4.31) <0.0001
Non-cardiac 1681 25 1.58 0.81 (0.52 to 1.26) 0.35
ECG normal
Normal 7291 128 1.86 1
Abnormal 1471 105 8.24 4.37 (3.38 to 5.66) <0.0001
_*Per 1000 person-years.
CAD, coronary artery disease; DBP diastolic blood pressure; SBP, systolic blood pressure.
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Added value of PISA model
Observed 10-year coronary mortality increased progressively
with updated Diamond-Forrester estimates of disease probability
ranging from 0.2% to 25.4% in groups with probability esti-
mates of coronary disease <10% and >90%, respectively (table
3). Only in groups with a disease probability >30% was the
10-year coronary mortality >1%, representing an annualised
mortality rate of only 0.1%. Similar patterns of increasing
cardiovascular and all-cause mortality were observed as the pre-
dicted risk of coronary disease increased. However, when the
PISA model was simpliﬁed to incorporate only those factors
used in the updated Diamond-Forrester diagnostic model (age,
sex, and character of symptoms), it caused it to underestimate
the predicted coronary mortality risk compared with the full
PISA model, particularly in patients with reversible risk factors
(see online supplementary tables S4 and S5). For example, if the
predictor variables are entered into the PISA online risk calcula-
tor for a 68-year-old man with atypical chest pain and diabetes
who is a non-smoker with a heart rate of 80 beats/min and an
abnormal ECG, the read-out for estimated 10-year coronary
mortality is 14%, with a 62% probability of obstructive coron-
ary disease (ﬁgure 1). If the simpliﬁed model is applied in the
same patient, restricted to those factors used in the updated
Diamond-Forrester diagnostic model (age, sex, character of
symptoms), the coronary mortality risk is substantially underes-
timated at only 5%.
DISCUSSION
We have analysed long-term outcomes in 8762 patients present-
ing for the ﬁrst time with suspected angina. A prognostic model
is presented based on clinical factors routinely available at the
initial cardiac assessment. The model discriminated powerfully
between patients at high risk and at lower risk of coronary mor-
tality during the 10-year follow-up period. Its potential clinical
utility was reﬂected in the prognostic value it added to the
updated Diamond-Forrester estimates of disease probability.2 To
exploit clinical utility we have developed a user-friendly online
PISA calculator that can be used in the consulting room to
inform clinical decision-making.
International guidelines emphasise the importance of the clin-
ical history in evaluating the patient with stable chest pain.4–6
However, while diagnostic models are widely used for assessing
the probability of coronary disease, the only available prognostic
Figure 1 Diagrammatic screen shot
of online prognosis in suspected
angina (PISA) calculator for predicting
the risks of coronary and
cardiovascular mortality and the
probability of obstructive coronary
artery disease in patients with
previously undiagnosed stable chest
pain.
Table 2 Multivariable predictors of coronary death (n=8762, 233
coronary deaths)
Variable HR (95% CI) p Value
Age (per 10 years) 2.33 (2.05 to 2.65) <0.0001
Sex
Female 1 <0.0001
Male 1.91 (1.45 to 2.52)
Character symptoms
Atypical 1 0.0043
Typical 1.59 (1.20 to 2.12)
Non-cardiac 1.05 (0.67 to 1.63)
Pulse rate (per 10 bpm) 1.22 (1.13 to 1.33) <0.0001
Current smoker
No 1 0.0016
Yes 1.64 (1.21 to 2.23)
Diabetes (y/n)
No 1 <0.0001
Yes 1.99 (1.46 to 2.70)
ECG normal
Normal 1 <0.0001
Abnormal 1.96 (1.49 to 2.59)
Harrell’s C=0.83.
Adding hospital to the above model (non-Newham vs Newham) HR: 1.01 (95% CI
0.77 to 1.32), p=0.29.
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models are those developed in populations with established
disease.13–15 These are high-risk populations of little relevance
to patients presenting for the ﬁrst time with suspected angina,
only a minority of whom have obstructive CAD to account for
their symptoms.16 17 Overall risk in such patients is low; the
recent Scot-Heart trial, which recruited 9849 patients with sus-
pected angina, reporting an estimated cardiovascular mortality
of only 0.3% during a median 1.7 years of follow-up.17 Risk,
however, is spread more widely than among patients with estab-
lished coronary disease, and discrimination of the high risk
minority from the lower risk majority, many of whom will have
unobstructed coronary arteries, is central to clinical evaluation
and management strategies. Guidelines recommend risk assess-
ment based on the results of non-invasive tests4–6 even though
the incremental value of such tests may be limited, the exercise
ECG, for example, adding little to the diagnostic or prognostic
information provided by the clinical assessment.16 18 This has
provoked calls for more effective methods of risk stratiﬁcation
in this group of patients in order that high-risk subgroups might
be identiﬁed for more intensive investigation and treatment.19
The prognostic model developed in our study provides a
ready means of risk-stratifying patients with suspected angina,
being based on factors that are always available at the ﬁrst clin-
ical evaluation in the consulting room. Consideration of just
seven factors—age, sex, typicality of symptoms, diabetes,
smoking status, heart rate, ECG changes—permitted estimation
of 10-year coronary mortality with excellent discrimination
between patients in the highest and the lower risk quarters, as
reﬂected in the 0.83 C statistic. The highest risk quarter
accounted for >75% of coronary deaths during follow-up, the
Kaplan-Meier estimate of 10-year mortality being close to 9%
compared to <1% in the lowest risk quarter. The risk factors
incorporated in the PISA model are well recognised, but in the
present study their inﬂuence on coronary mortality in a chest
pain clinic population has been quantiﬁed for the ﬁrst time with
the development of a desk-top PISA calculator for use in the
clinical setting. Discrimination between high and low risk
patients provided by the prognostic model identiﬁes it as a
potentially important clinical tool for selecting those patients
with suspected angina who might beneﬁt from more intensive
investigation and treatment. Importantly, our data showed that
prognosis inferred from the factors included in the updated
Diamond-Forrester diagnostic model underestimated coronary
mortality, particularly in patients with risk factors such as dia-
betes for whom chest pain presentations may be atypical,
masking signiﬁcant coronary mortality risk.20
Guidelines recommend that decisions about the further inves-
tigation of patients with suspected angina should be informed
by probability estimates of CAD,4–6 but these estimates are
often exaggerated in contemporary populations and updated
models have been developed that have already penetrated inter-
national guidelines.2 16 These updated models, however, like
their predecessors, were developed in angiographic populations
and it remains likely that they overestimate disease probability
in the lower risk populations presenting for the ﬁrst time with
suspected angina. Thus, we found that only in groups with a
Diamond-Forrester estimate of disease probability >30% was
the observed 10-year coronary mortality >1%, representing an
annualised mortality rate of only 0.1%. Even groups with an
estimated probability of coronary disease of 60–90% (mean
74%) had an annualised coronary mortality rate of only 0.7%.
This apparent mismatch between disease risk and mortality risk
emphasises the importance of considering both diagnostic and
prognostic indicators in patients with suspected angina in order
that those at greatest risk might be identiﬁed.
The PISA web-based tool we developed has the potential to
enhance the clinical assessment of patients with suspected
Figure 2 Kaplan-Meier cumulative
coronary mortality by quarters of risk
for the full prognostic model (based on
table 2). There were 5, 14, 41, and
173 coronary deaths in risk groups 1
(lowest risk quarter) to 4 (highest risk
quarter), respectively.
Table 3 Observed 10-year mortality by updated
Diamond-Forrester estimates of coronary disease probability
Predicted
risk
group of
CAD (%) Total
Mean
predicted
risk of
CAD (%)
Mortality*
Coronary Cardiovascular All-cause
<10 537 7.1 1 (0.2%) 5 (0.9%) 12 (2.3%)
10 to <30 3088 19.5 23 (0.8%) 51 (1.7%) 161 (5.3%)
30–60 3296 43.5 81 (2.6%) 124 (3.9%) 312 (9.6%)
>60–90 1753 74.2 111 (6.8%) 156 (9.6%) 387 (22.5%)
>90 88 91.2 17 (25.4%) 28 (39.1%) 52 (60.4%)
*Percentages from Kaplan-Meier estimate at 10 years.
CAD, coronary artery disease.
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angina by providing quantitative estimates of both disease prob-
ability, using the updated diagnostic model of Genders et al,
and coronary and cardiovascular mortality using the prognostic
model developed in our chest pain clinic population. The prog-
nostic model was designed to identify high risk patients present-
ing for the ﬁrst time with stable chest pain, and only those
demographic and clinical factors consistently available at the
ﬁrst consultation were considered. Not considered, therefore,
were factors that might later become available including the
results of investigations such as non-invasive ischaemia tests and
circulating lipid concentrations. For the same reason, treatment
strategies adopted during the 10 years of follow-up were also
not considered. Despite this, model performance was excellent
based on just seven predictor variables which, when entered
into the PISA web-based tool, provide a reliable estimate of
10-year coronary and cardiovascular mortality risk in patients
with suspected angina. Use of the full model with entry of all
seven predictor variables is important because prognostic assess-
ment based simply on age, sex, and character of symptoms—the
factors that populate the Diamond-Forrester model for estimat-
ing disease probability—takes no account of contributions made
by risk factors, heart rate, and ECG ﬁndings, resulting in vari-
able underestimation of mortality risk. Because data were col-
lected across six different UK centres, the PISA risk estimates
are likely to be generalisable, but further validation studies will
be needed to conﬁrm this.
Strengths of our study include the large multicentre patient
population, the contemporaneous recording of chest pain
characteristics and other clinical factors available at ﬁrst consult-
ation in a purpose built electronic registry, and the ascertain-
ment of long-term cause-speciﬁc mortality through linkage with
the UK national death registry. It was our main purpose to
develop a prognostic model for utilisation at the ﬁrst clinic
attendance before instigation of further testing or speciﬁc treat-
ments. Nevertheless, the potential for treatment and lifestyle
changes to distort the risk prediction is a relevant consideration
and emphasises the importance of measuring model discrimin-
ation over a prolonged period and validating the model in dif-
ferent populations. The fact that the model discriminated
powerfully between risk groups during 10 years of follow-up,
with comparable validity in two separate chest pain clinic popu-
lations, speaks to its utility independently of subsequent treat-
ment and lifestyle change. Completion of the baseline data
collection 12 years ago is a limitation, but allowed collection of
the follow-up data and development of the long-term prognos-
tic model that was the primary aim of this study. Other poten-
tial limitations relating to bias in patient selection, data
recording, and catchment population characteristics were mini-
mised by including consecutive patients with suspected angina,
utilising a standardised database across study centres and
recruiting from six different study centres in urban and subur-
ban environments.
The broad spectrum of risk that characterises patients present-
ing with suspected angina challenges clinicians to identify the
minority at high risk of coronary events. This can be achieved
using the prognostic model and PISA online calculator devel-
oped in our study. The model is based on simple clinical factors
available at the initial consultation and has the potential to com-
plement diagnostic models of disease probability in identifying
high-risk patients with suspected angina who merit more inten-
sive investigation and treatment.
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